Back to results
US 2026/0062743 A1Published application
Detection of minimal residual disease from surgical drain fluid
AssigneeDroplet Biosciences, Inc.
InventorsZhuosheng Gu, Wendy Winckler Adamovich
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for detecting and predicting minimal residual disease in a subject who has undergone tumor resection surgery. Methods of the invention utilize a personalized cutoff for determining the likelihood for MRD.
Claims11
A method for establishing a personalized cutoff of minimal residual disease, the method comprising:
- determining a depth of coverage of one or more mutations suspected to be present in a liquid biopsy sample obtained from a cancer patient;
- sequencing nucleic acid in the sample at the determined depth of coverage to determine a number of a somatic mutation in the sample;
- and
- establishing a personalized cutoff for the cancer patient based upon the number of somatic mutations and depth of coverage,
- wherein subsequent results above the personalized cutoff indicate a recurrence of cancer.
2 more elements
Dependencies are inferred from the claim text.